Table 7. Comorbidities.
| CLL; n (% of all CLL patients) | FL; n (% of all FL patients) | |
|---|---|---|
| Atrial fibrillation | 1 (12,5) | 1 (14,3) |
| Coronary artery disease | 2 (25) | 0 |
| Diabetes mellitus type II | 2 (25) | 0 |
| Hematologic comorbidities | 0 | 1 previous DLBCL (14,3) |
| Hepatitis C | 0 | 1 eradicated Hepatitis C (14,3) |
Abbreviations: DLBCL: Diffuse Large B-cell Lymphoma.